Global Precision Medicine Market research report by Emergen Research delivers a comprehensive analysis of the market outlook, regulatory framework, and macro- and micro-economic factors influencing the growth of the market. The report is formulated through extensive research and surveys to offer accurate and authentic information about the market size, market share, product portfolio, revenue generation, and projected market growth. The report offers key insights into the competitive and regional landscape of the market to assist the stakeholders and investors in formulating strategic business plans.

In today's competitive marketplace, staying ahead of the curve is essential for businesses of all sizes. Understanding consumer behavior, market trends, and emerging opportunities is crucial for making informed decisions and developing effective strategies. Emergen Research recognizes this need and has invested significant resources in developing a cutting-edge market research content library. 

The newly launched Precision Medicine market research content is meticulously crafted by industry experts, leveraging extensive data analysis, and a deep understanding of various markets. This rich collection includes in-depth reports, whitepapers, case studies, trend analyses, and industry insights covering a wide range of sectors, including but not limited to technology, healthcare, finance, consumer goods, and manufacturing. 

Key points covered in the report:

  • A detailed outlook of the market with essential data beneficial for business
  • Market segmentation based on product types, applications, and end-users. For further understanding, the key segments are further divided into sub-segments
  • Growth factors, driving and restraining factors, product trends, and technological advancements are extensively discussed
  • Latest product developments, incorporation of new techniques and profiles of major competitors
  • An 8-year forecast estimation detailing the growth and expansion scope of the Precision Medicine market
  • In-depth analysis of the forecast period (2024-2034)
  • Market dynamics with information of players, challenges, restraints, threats, and opportunities
  • SWOT analysis and Porter’s Five Forces analysis of the top vendors

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/32 

The global precision medicine market size was USD 57.69 Billion in 2021 and is expected to register a rapid revenue CAGR of 11.5% during the forecast period. Precision medicine market revenue growth is primarily driven by factors such as advancement in cancer biology, increased adoption of gene therapy globally, rising use of big data analytics in precision medicine in developed economies, and patient’s involvement in personal healthcare. Precision medicine is an emerging field, which guides therapy according to individual’s genetic makeup, environment, and lifestyle. It helps medical professionals and scientists to develop more precise diagnoses, prognoses, and preventative measures for every given disease. In addition, goal of precision medicine, often known as customized medicine or tailored medicine, is targeting specific mutations that turn healthy cells into malignant ones. Precision medicine's focused treatments, especially for cancer, have fewer adverse effects and faster recoveries compared to standard medicine.

Moreover, advancement in precision medicine has already resulted in significant new discoveries and treatments that have been approved by FDA. These treatments are tailored to particular traits of individuals, such as a person's genetic makeup or genetic profile of a patient's tumor and they have shown great promise for treatment of various diseases. As a standard component of patient care, patients suffering from a wide variety of cancers are put through molecular testing. Furthermore, this gives doctors ability to select therapies that both improve patients' odds of surviving cancer and lower risk of experiencing harmful side effects.

 

Competitive Landscape: 

The latest study provides an insightful analysis of the broad competitive landscape of the global Precision Medicine market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. 

Increased usage of Next Generation Sequencing (NGS) is also driving market revenue growth. NGS technologies are capable of speedily identifying or sequencing substantial portion of an individual's genome and represent significant improvements in the real-world applications of precision medicine. Using these tests physicians, patients, and researchers can identify genetic variants that aid in diagnosis, treatment, and comprehension of human disease. FDA's goal for advancing precision medicine is to assure accuracy of NGS testing so that patients and physicians receive clinically relevant test results. In addition, large amount of data generated by NGS presents FDA with significant regulatory challenges. Current regulatory approaches are suitable for conventional diagnostics that detect a particular condition or disease (such as blood sugar or cholesterol levels), but these advancements in sequencing technologies are equivalent of millions of tests in one. As a result, FDA has collaborated with stakeholders in the sector, research labs, academic institutions, and patient and medical communities to create a flexible regulatory system to accommodate this constantly developing technology that uses consensus standards, crowd-sourced data, and cutting-edge accessible computing technologies to support NGS test development. This strategy facilitates innovation in research and testing and expedites availability of accurate and reliable genetic diagnostics.

Personalized Medicine (PM), or precision medicine in oncology, is a new method for treating and preventing cancer that takes into consideration individual's unique genetic makeup, tumor microenvironment (immune system), lifestyle, and comorbidities. PM has the ability to alter tumor immunological environment and target oncogenic pathways of tumor, allowing for more specific and effective treatment. In addition, PM considers therapy-induced toxicities for each individual patient in an effort to maximize tumor response. Thus, organ function and, by extension, quality of life is preserved while tumor response is optimized. These are other key factors driving market revenue growth.

 

Emergen Research is Offering a full report (Grab a Copy Now) @ https://www.emergenresearch.com/industry-report/precision-medicine-market

The global precision medicine market size was USD 57.69 Billion in 2021 and is expected to register a rapid revenue CAGR of 11.5% during the forecast period. Precision medicine market revenue growth is primarily driven by factors such as advancement in cancer biology, increased adoption of gene therapy globally, rising use of big data analytics in precision medicine in developed economies, and patient’s involvement in personal healthcare. Precision medicine is an emerging field, which guides therapy according to individual’s genetic makeup, environment, and lifestyle. It helps medical professionals and scientists to develop more precise diagnoses, prognoses, and preventative measures for every given disease. In addition, goal of precision medicine, often known as customized medicine or tailored medicine, is targeting specific mutations that turn healthy cells into malignant ones. Precision medicine's focused treatments, especially for cancer, have fewer adverse effects and faster recoveries compared to standard medicine.

Moreover, advancement in precision medicine has already resulted in significant new discoveries and treatments that have been approved by FDA. These treatments are tailored to particular traits of individuals, such as a person's genetic makeup or genetic profile of a patient's tumor and they have shown great promise for treatment of various diseases. As a standard component of patient care, patients suffering from a wide variety of cancers are put through molecular testing. Furthermore, this gives doctors ability to select therapies that both improve patients' odds of surviving cancer and lower risk of experiencing harmful side effects.

 

Market Segmentation: 

The report bifurcates the Precision Medicine market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. 

The global precision medicine market is fairly fragmented, with a number of large and medium-sized players accounting for majority market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective solutions.

Some major companies included in the global precision medicine market report are:

  • Biocrates Life Sciences AG
  • Tepnel Pharma Services Limited
  • Novartis AG  
  • Qiagen
  • Quest Diagnostics Incorporated
  • Abbott
  • AB-Biotics, S.A.
  • General Electric Company
  • Caris Life Sciences
  • Pfizer, Inc.  
  • F. Hoffman-La Roche Ltd.

 

Our goal at Emergen Research is to empower businesses with the knowledge and insights necessary to make informed decisions and thrive in today's dynamic business landscape. Our market research content is designed to equip professionals and organizations with comprehensive analyses, actionable recommendations, and a competitive edge to achieve their growth objectives. 

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/32 

For the purpose of this report, Emergen Research has segmented the global precision medicine market based on technology, application, end-use, and region:

  • Technology Outlook (Revenue, USD Billion; 2019-2030)

    • Big-Data Analytics
    • Bioinformatics
    • Gene Sequencing
    • Drug Discovery
    • Companion Diagnostics
    • Others

  • Application Outlook (Revenue, USD Billion; 2019-2030)

    • Oncology
    • Immunology
    • Central Nervous System (CNS)
    • Respiratory
    • Others

  • End-Use Outlook (Revenue, USD Billion; 2019-2030)

    • Pharmaceutical Companies
    • Diagnostic Companies
    • Healthcare IT Companies
    • Others

  • Regional Outlook (Revenue, USD Billion; 2019–2030)

    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa

Target Audience of the Global Precision Medicine Market Report: 

  • Key Market Players 
  • Investors 
  • Venture capitalists 
  • Small- and medium-sized and large enterprises 
  • Third-party knowledge providers 
  • Value-Added Resellers (VARs) 
  • Global market producers, distributors, traders, and suppliers 
  • Research organizations, consulting companies, and various alliances interested in this sector 
  • Government bodies, independent regulatory authorities, and policymakers 

The global precision medicine market size was USD 57.69 Billion in 2021 and is expected to register a rapid revenue CAGR of 11.5% during the forecast period. Precision medicine market revenue growth is primarily driven by factors such as advancement in cancer biology, increased adoption of gene therapy globally, rising use of big data analytics in precision medicine in developed economies, and patient’s involvement in personal healthcare. Precision medicine is an emerging field, which guides therapy according to individual’s genetic makeup, environment, and lifestyle. It helps medical professionals and scientists to develop more precise diagnoses, prognoses, and preventative measures for every given disease. In addition, goal of precision medicine, often known as customized medicine or tailored medicine, is targeting specific mutations that turn healthy cells into malignant ones. Precision medicine's focused treatments, especially for cancer, have fewer adverse effects and faster recoveries compared to standard medicine.

Moreover, advancement in precision medicine has already resulted in significant new discoveries and treatments that have been approved by FDA. These treatments are tailored to particular traits of individuals, such as a person's genetic makeup or genetic profile of a patient's tumor and they have shown great promise for treatment of various diseases. As a standard component of patient care, patients suffering from a wide variety of cancers are put through molecular testing. Furthermore, this gives doctors ability to select therapies that both improve patients' odds of surviving cancer and lower risk of experiencing harmful side effects.

 

About Emergen Research  

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. 

Contact Us: 

Eric Lee 

Corporate Sales Specialist 

Emergen Research | Web: https://www.emergenresearch.com/ 

Direct Line: +1 (604) 757-9756 

E-mail: sales@emergenresearch.com